Clarke Barlow
Vermogen: 3 733 $ op 31-07-2026
Vermogen: 3 733 $ op 31-07-2026
Clarke Colin Barlow is the founder of AMG Acquisition Corp., founded in 2021, serving as Independent Director since 2021.
Current jobs include Non-Executive Director at Neuroscientific Biopharmaceuticals Ltd. since 2023 and Member at Australian Institute of Co. Directors.
Former jobs include Non-Executive Director at Exopharm Ltd. and Non-Executive Director at Entropy Neurodynamics Ltd. in 2024.
Education includes undergraduate studies at The University of Western Australia.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AMG ACQUISITION CORP. 11,59% | 06-05-2025 | 533.340 ( 11,59% ) | 3 733 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AMG ACQUISITION CORP. | Oprichter | 01-06-2021 |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Directeur/Bestuurslid | 17-11-2023 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| EXOPHARM | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
AMG Acquisition Corp.
AMG Acquisition Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau